In a previous study, needle-based VNS decreased the plasma level of TNF-α and IL-6 in a rodent model of 2,4,6-trinitrobenzene sulfonic acid–induced (TNBS-induced) colitis by inhibiting proinflammatory cytokines via the autonomic mechanism (52). This evidence concerns the gene TNF and colitis.